Viewing Study NCT07110194

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-24 @ 9:18 AM
Study NCT ID: NCT07110194
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-07
First Post: 2025-07-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CD20-positive Hematological Malignancies View
Keywords: